Afghanistan

in page functions
[French]
Total population (2016) 33,369,916
Birth cohort (2016) 1,081,810
Surviving Infants (surviving to 1 year per year, 2016) 1,010,762
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 66/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 91/1000
World Bank Index, IDA (2012) 2.63
Co-financing status (2016) Initial self-financing
No. of districts/territories (2014) 329

Gavi support for Afghanistan

Type of support

Approvals

2001-2020 (US$)
(30 Apr 2016)

Commitments

2001-2020 (US$)
(30 Apr 2016)

Disbursements

2000-2016 (US$)
(30 Apr 2016)

% Disbursed

(30 Apr 2016)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Civil Society Organisation support (CSO) $3,576,400 $3,576,400 $3,892,300 109%
Health system strengthening (HSS 1) $34,100,000 $34,100,000 $34,100,000 100%
Health system strengthening (HSS 2) $15,914,478 $15,914,478 $15,914,478 100%
Health system strengthening (HSS 3) $11,749,734 $39,898,858
Immunisation services support (ISS) $14,025,300 $14,025,300 $13,855,800 99%
Injection safety support (INS) $1,676,500 $1,676,500 $1,676,500 100%
IPV (NVS) $1,956,500 $2,669,000 $1,365,726 70%
Measles SIA (NVS) $2,163,903 $2,163,903 $2,163,903 100%
Measles SIA - Operational costs (OPC) $3,574,000 $3,574,000 $3,574,000 100%
Penta (NVS) $67,730,147 $67,730,147 $65,743,548 97%
Pneumo (NVS) $70,643,894 $70,643,894 $67,576,786 96%
Tetra DTP-HepB (NVS) $9,903,633 $9,903,633 $9,903,633 100%
Vaccine Introduction Grant (VIG) $2,512,000 $2,512,000 $2,512,000 100%
Total $239,526,490 $268,388,113 $222,278,674

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Afghanistan DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2014)

Grade of confidence


N/A
DTP3 - Official country estimates (2014) 95%
M:F sex ratio at birth (2016) 1.06
Household survey: DTP3 coverage for male (2010) 41.60%
Household survey: DTP3 coverage for female (2010) 38.90%
Household survey: Last DTP3 survey (2010) 40%
% districts achieving > 80% DTP3 coverage (2014) 68%
% districts achieving < 50% DTP3 coverage (2014) 9%
MCV WHO/UNICEF estimates (2014) 66%

Breakdown of support

Non-vaccine support Vaccine support
34% 66%
$75,525,078 $146,753,594

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Afghanistan

02 November 2015

Afghanistan airport

Afghanistan ensures safe passage of life-saving vaccines

Afghan health ministry shows commitment to immunisation by opening critical storage facility at central airport.

30 September 2015

Afghanistan IPV

New polio vaccine introduced to accelerate polio eradication in Afghanistan

More than one million children to benefit from the new polio vaccine

20 August 2015

Pakistan IPV

More than four million children per year in Pakistan to benefit from new injectable polio vaccine

Polio-endemic country takes another step towards a polio-free future as it introduces IPV into its routine immunisation programme, as part of largest globally coordinated vaccine introduction in history (joint press release Pakistan MoH, UNICEF, GPEI, WHO, Gavi).

close icon

modal window here